SEC Form 4 · accession 0001140361-16-070717
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marcus E. Smith
Director
Period of report
Jun 22, 2016
Accepted (ET)
Jun 23, 2016 · 9:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $0.95 | Jun 22, 2016 | A | 36,000 | A | — | Jun 22, 2026 | Common Stock | 36,000 | 36,000 | D |
Explanation of responses
- F1This option is exercisable on the earlier of (i) June 22, 2017 or (ii) the date of the issuer's 2017 Annual Meeting of Stockholders, subject to the grantee's continued service on the Board of Directors of the issuer through this date.